Alternate links: Google News | Twitter

Vance's VC firm also backs a $200 million biotech startup called AmplifyBio. In addition to Narya's holdings, Vance declared he personally owns as much as $100,000 in the company's non-public stock, according to recent SEC disclosures. The drug-testing firm has been lauded in the local press as part of Ohio's transition from rust-belt decay to high-tech rebirth. The firm touts its mission as: "Advancing Science for Humankind." But behind the gleaming walls of its Columbus-area campus, AmplifyBio operates a disturbing enterprise. Its core business is testing experimental drugs developed by other companies. AmplifyBio tests many of these substances on live animals, including monkeys and dogs. Many of these animals die in the course of toxic testing exposures. Other animals are destroyed at the conclusion of testing. There are also dreadful mistakes: A lab monkey recently died after getting wedged in faulty lab equipment, and technician error left other monkeys with burns on their genitals.